Edward Gelmann, M.D.
Dr. Edward Gelmann was involved in both the early laboratory research
on the cause of AIDS and the early clinical programs in caring for AIDS
patients at the NIH hospital, the Clinical Center.
He developed an interest in retroviruses when he was in medical school
at Stanford University and joined the laboratory of Dr. Robert Gallo at
the NIH in 1979 as a postdoctoral fellow to work on viral and human oncogenes.
When AIDS first appeared, he was one of the scientists, in company with
Dr. Gallo and other researchers, who began to explore the possibility
that it was caused by a retrovirus. He moved from laboratory research
in 1983 and became involved in clinical programs relating to Kaposi's
sarcoma at the Clinical Center. He describes the “rich and fruitful"
collaboration that developed between NIAID and NCI researchers in the
clinical studies relating to AIDS patients in the Clinical Center and
the excellent cooperation of these patients in the studies in which they
Dr. Gelmann continued to work with AIDS patients at the NIH until
AZT and anti-viral therapy became the main focus of clinical trials.
In 1988, he moved to Georgetown University and became Professor of
Medicine and Oncology at the Lombardi Cancer Center. He conducts basic
and clinical research on prostate cancer. In 2002, he was appointed to
the Dr. William M. Scholl Chair in Medical Oncology.
|Edward Gelmann, M.D.